While it is encouraging that SHN3-deficient Col1a2oim/oim mice display a restoration of bone formation parameters, the most clinically relevant endpoint is the prevention of fractures, the major source of morbidity in clinical OI. This evidence concerns the gene HIVEP3 and osteogenesis imperfecta.